Abstract
Herein we report a drug delivery system based on hollow iron silicate nanospheres. Fe3+ on the nanospheres' surface can effectively bind with doxorubicin (DOX), an anticancer drug, through coordination bonds. The bonds are fairly stable in a neutral environment but could easily break up in an acid environment. The release of DOX from hollow iron silicate nanospheres into cancer cells can be therefore triggered by a pH drop caused by endocytosis. The iron silicate shell allows a DOX loading content of up to 50.2% in weight, which is significantly higher than most drug delivery systems reported. Cell experiments show that DOX-loaded hollow iron silicate nanospheres exhibit a higher efficiency in killing cancer cells than free DOX, and a higher cytotoxicity for human hepatoma cells than hepatocyte cells at the same DOX-loaded nanospheres' concentration. Confocal laser scanning microscopy (CLSM) experiments show the releasing and transportation process of DOX, and confirm the enrichment of DOX in cell nuclei.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.